These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

632 related items for PubMed ID: 23867111

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Functional Categorization of BRCA1 Variants of Uncertain Clinical Significance in Homologous Recombination Repair Complementation Assays.
    Bouwman P, van der Heijden I, van der Gulden H, de Bruijn R, Braspenning ME, Moghadasi S, Wessels LFA, Dutch-Belgian VUS workgroup, Vreeswijk MPG, Jonkers J.
    Clin Cancer Res; 2020 Sep 01; 26(17):4559-4568. PubMed ID: 32546644
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance.
    Langerud J, Jarhelle E, Van Ghelue M, Ariansen SL, Iversen N.
    Hum Genomics; 2018 Nov 20; 12(1):51. PubMed ID: 30458859
    [Abstract] [Full Text] [Related]

  • 6. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL, Smith AM, Dávila MR, Sigurdson AJ, Giusti RM, Pineda MA, Doody MM, Tucker MA, Greene MH, Zhang J, Struewing JP.
    Hum Mutat; 2003 Aug 20; 22(2):121-8. PubMed ID: 12872252
    [Abstract] [Full Text] [Related]

  • 7. Structure-based assessment of missense mutations in human BRCA1: implications for breast and ovarian cancer predisposition.
    Mirkovic N, Marti-Renom MA, Weber BL, Sali A, Monteiro AN.
    Cancer Res; 2004 Jun 01; 64(11):3790-7. PubMed ID: 15172985
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of BRCA1 BRCT Variants on Cancer Risk.
    Petitalot A, Dardillac E, Jacquet E, Nhiri N, Guirouilh-Barbat J, Julien P, Bouazzaoui I, Bonte D, Feunteun J, Schnell JA, Lafitte P, Aude JC, Noguès C, Rouleau E, Lidereau R, Lopez BS, Zinn-Justin S, Caputo SM, UNICANCER Genetic Group BRCA network.
    Mol Cancer Res; 2019 Jan 01; 17(1):54-69. PubMed ID: 30257991
    [Abstract] [Full Text] [Related]

  • 11. A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast/ovarian cancer patients.
    Sanz DJ, Acedo A, Infante M, Durán M, Pérez-Cabornero L, Esteban-Cardeñosa E, Lastra E, Pagani F, Miner C, Velasco EA.
    Clin Cancer Res; 2010 Mar 15; 16(6):1957-67. PubMed ID: 20215541
    [Abstract] [Full Text] [Related]

  • 12. PARP inhibitors: targeting the right patients.
    Azvolinsky A.
    J Natl Cancer Inst; 2012 Dec 19; 104(24):1851-2. PubMed ID: 23231976
    [No Abstract] [Full Text] [Related]

  • 13. BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1.
    Drost R, Dhillon KK, van der Gulden H, van der Heijden I, Brandsma I, Cruz C, Chondronasiou D, Castroviejo-Bermejo M, Boon U, Schut E, van der Burg E, Wientjens E, Pieterse M, Klijn C, Klarenbeek S, Loayza-Puch F, Elkon R, van Deemter L, Rottenberg S, van de Ven M, Dekkers DH, Demmers JA, van Gent DC, Agami R, Balmaña J, Serra V, Taniguchi T, Bouwman P, Jonkers J.
    J Clin Invest; 2016 Aug 01; 126(8):2903-18. PubMed ID: 27454287
    [Abstract] [Full Text] [Related]

  • 14. Twenty-three novel BRCA1 and BRCA2 sequence variations identified in a cohort of Swiss breast and ovarian cancer families.
    Maillet P, Chappuis PO, Khoshbeen-Boudal M, Sciretta V, Sappino AP, SIAK Network for Cancer Predisposition Testing and Counseling.
    Cancer Genet Cytogenet; 2006 Aug 01; 169(1):62-8. PubMed ID: 16875939
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.